We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

26 hedge funds and large institutions have $5.7M invested in NanoViricides in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

53% more capital invested

Capital invested by funds: $3.74M → $5.7M (+$1.96M)

0% more funds holding

Funds holding: 26 → 26 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.39% less ownership

Funds ownership: 8.79% → 8.4% (-0.39%)

Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.85M
2
Bank of America
Bank of America
North Carolina
+$749K
3
BCM
Bridgeway Capital Management
Texas
+$153K
4
Northern Trust
Northern Trust
Illinois
+$114K
5
Morgan Stanley
Morgan Stanley
New York
+$56.7K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.62M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$287K
3
Citadel Advisors
Citadel Advisors
Florida
-$122K
4
HIS
Harvest Investment Services
Illinois
-$109K
5
WS
Wedbush Securities
California
-$59K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$2.01M +$1.85M +266,648 +16,151%
Bank of America
2
Bank of America
North Carolina
$808K +$749K +107,844 +60,929%
Goldman Sachs
3
Goldman Sachs
New York
$663K -$1.62M -232,738 -72%
Vanguard Group
4
Vanguard Group
Pennsylvania
$644K – – –
Morgan Stanley
5
Morgan Stanley
New York
$409K +$56.7K +8,154 +18%
BCM
6
Bridgeway Capital Management
Texas
$302K +$153K +22,000 +119%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$300K – – –
VF
8
Virtu Financial
New York
$188K +$174K +25,092 New
WBG
9
Wharton Business Group
Pennsylvania
$136K – – –
Northern Trust
10
Northern Trust
Illinois
$123K +$114K +16,386 New
Wells Fargo
11
Wells Fargo
California
$30K -$21 -3 -0.1%
FDCDDQ
12
Federation des caisses Desjardins du Quebec
Quebec, Canada
$22.5K – – –
BCWM
13
Bartlett & Co Wealth Management
Ohio
$15.2K – – –
BC
14
Bartlett & Co
Ohio
$15K – – –
Citigroup
15
Citigroup
New York
$11K +$10.3K +1,478 New
Osaic Holdings
16
Osaic Holdings
Arizona
$10K +$6.95K +1,000 +238%
EWA
17
Evolution Wealth Advisors
Florida
$4K – – –
PCG
18
Private Capital Group
Connecticut
$3K – – –
CA
19
Clearstead Advisors
Ohio
$2K – – –
SSB
20
Sandy Spring Bank
Maryland
$2K – – –
TWP
21
TFO Wealth Partners
Ohio
$2K – – –
UBS Group
22
UBS Group
Switzerland
$1K -$32.7K -4,712 -98%
EWM
23
Edge Wealth Management
New York
$1K +$1.39K +200 New
RE
24
RBC Europe
United Kingdom
$60 – – –
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
– -$287K -50,000 Closed
1
2

NNVC Hedge Fund Activity: Q2 2020 in Review

26 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2020, worth a combined $5.7M — up 53% from $3.74M a quarter earlier.

Fund positioning in NNVC was balanced in Q2 2020: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $1.85M. The largest seller was Goldman Sachs, cutting an estimated $1.62M.

  • 26 institutional investors held NanoViricides (NNVC) as of Q2 2020, unchanged from Q1 2020.
  • Funds reported $5.7M of NanoViricides stock for Q2 2020, up 53% quarter-over-quarter.
  • 4 funds opened new NanoViricides positions in Q2 2020 and 4 closed out, a net change of 0 holders.
  • The largest NanoViricides buyer in Q2 2020 was BlackRock, an estimated $1.85M added.
  • The largest NanoViricides seller in Q2 2020 was Goldman Sachs, an estimated $1.62M sold.

Based on aggregated 13F filings for Q2 2020.